Astellas Pharma saw the highest growth of 99% in patent filings and 142% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 81% and grants by 81%. GlobalData’s DataBook provides a comprehensive analysis of Astellas Pharma‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Astellas Pharma has been focused on protecting inventions in United States(US) with 28 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 17% filings and 23% grants. The World Intellectual Property Organization(WIPO), United States(US), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Astellas Pharma is filings its patents. Among the top granted patent authorities, Astellas Pharma has 23% of its grants in United States(US), 15% in Japan(JP) and 4% in European Patent Office(EPO).

F. Hoffmann-La Roche and Bristol-Myers Squibb could be the strongest competitors for Astellas Pharma

Patents related to rare diseases and healthtech lead Astellas Pharma's portfolio

Astellas Pharma has the highest number of patents in rare diseases followed by, healthtech and cell & gene therapy. For rare diseases, nearly 48% of patents were filed and 54% of patents were granted in Q1 2024.

Lung cancer related patents lead Astellas Pharma portfolio followed by pancreatic cancer, and ovarian cancer

Astellas Pharma has highest number of patents in lung cancer followed by pancreatic cancer, ovarian cancer, head and neck cancer, and liver cancer. For lung cancer, nearly 5% of patents were filed and 4% of patents were granted in Q1 2024.

For comprehensive analysis of Astellas Pharma's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.